These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FDA notifications. Potential serious effect of combination saquinavir-ritonavir. AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774 [No Abstract] [Full Text] [Related]
5. Possible fatal interaction between protease inhibitors and methamphetamine. Hales G; Roth N; Smith D Antivir Ther; 2000 Mar; 5(1):19. PubMed ID: 10846588 [No Abstract] [Full Text] [Related]
6. Saquinavir plus ritonavir reduce viral load by 99.9 percent. Vazquez E Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983 [TBL] [Abstract][Full Text] [Related]
7. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin. Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762 [No Abstract] [Full Text] [Related]
8. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
9. [Diabetes and hyperglycemia in patients under treatment for HIV infection with the protease inhibitors indavir, ritonavir, saquinavir as well as nelfinavir (in development, but not yet released]. Pharm Unserer Zeit; 1997 Dec; 26(6):317. PubMed ID: 9513575 [No Abstract] [Full Text] [Related]
13. Saquinavir/Ritonavir: its evolution and current treatment role. O'Brien WA AIDS Read; 2006 Jan; 16(1):38-44; discussion 43. PubMed ID: 16433471 [TBL] [Abstract][Full Text] [Related]
15. Ritonavir and saquinavir combination: 12-week data at ICAAC. James JS AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880 [TBL] [Abstract][Full Text] [Related]
17. Combination study of Invirase and Norvir starting. AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633 [No Abstract] [Full Text] [Related]
18. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks. Bunupuradah T; van der Lugt J; Kosalaraksa P; Engchanil C; Boonrak P; Puthanakit T; Mengthaisong T; Mahanontharit A; Lumbiganon P; Tompkins E; Burger D; Ruxrungtham K; Ananworanich J; Antivir Ther; 2009; 14(2):241-8. PubMed ID: 19430099 [TBL] [Abstract][Full Text] [Related]
20. Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavir. Vandercam B; Moreau M; Horsmans C; Gala JL Infection; 1998; 26(5):313. PubMed ID: 9795794 [No Abstract] [Full Text] [Related] [Next] [New Search]